Health News
Pulmonary Arterial Hypertension Rx Combo Approved
Together, two medications for pulmonary arterial hypertension (PAH) may help patients even more than either pill alone.
FDA Drug Safety Communication: Letairis
The U.S. Food and Drug Administration (FDA) is removing the warning related to liver injury from the boxed warning of the Letairis ( ambrisentan ) tablet label.